2019
DOI: 10.32474/anoaj.1.5
|View full text |Cite
|
Sign up to set email alerts
|

Untitled

Abstract: It was known that nearly 65% of anti-cancer drugs granted market approved by FDA between 210-1015 are heterocyclic compounds and about 95% of heterocyclic compounds are drugs. Heterocyclic compounds containing nitrogen atoms in their structures (nitrogen based)were also proved by FDA during the above period that they form two third of cancer drugs. There are many corresponding reviews associated with the impact and usage of different heterocyclic compounds as anti-platelet, antihypertensions and a lot of biolo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 8 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?